Human/mouse CD137 agonist, JNU-0921, effectively shrinks tumors through enhancing the cytotoxicity of CD8+ T cells in cis and in trans
Article in Science Advances (August 2024)
The most recent citing publications are shown below. View all 92 publications that cite this research output on Dimensions.
Extracellular Vesicle Surface Display Enhances the Therapeutic Efficacy and Safety Profile of Cancer Immunotherapy
Article in Molecular Therapy (July 2024)
CAR-T lymphocyte-based cell therapies; mechanistic substantiation, applications and biosafety enhancement with suicide genes: new opportunities to melt side effects
Article in Frontiers in Immunology (July 2024)